Application 210864

Type: NDA
Sponsor: SEDOR PHARMS LLC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	SESQUIENT	FOSPHENYTOIN SODIUM	SOLUTION;INTRAVENOUS	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	Yes	Yes
002	SESQUIENT	FOSPHENYTOIN SODIUM	SOLUTION;INTRAVENOUS	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N210864-001	SESQUIENT	FOSPHENYTOIN SODIUM	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS		RLD	2020-11-05
N210864-002	SESQUIENT	FOSPHENYTOIN SODIUM	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS		RLD	2020-11-05

Orange Book patents#

Current patent rows page 1 of 1 · 10 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Coverage / status	Submission date
N210864-001	7635773	2029-03-13	Drug product	2020-12-01
N210864-001	8410077	2029-03-13	Drug product	2020-12-01
N210864-001	9200088	2029-03-13	Drug product	2020-12-01
N210864-001	9750822	2029-03-13	Drug product	2020-12-01
N210864-001	9493582	2033-02-27	Drug product	2020-12-01
N210864-002	7635773	2029-03-13	Drug product	2020-12-01
N210864-002	8410077	2029-03-13	Drug product	2020-12-01
N210864-002	9200088	2029-03-13	Drug product	2020-12-01
N210864-002	9750822	2029-03-13	Drug product	2020-12-01
N210864-002	9493582	2033-02-27	Drug product	2020-12-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 74 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N210864-001	SESQUIENT	EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N210864-002	SESQUIENT	EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)	SOLUTION / INTRAVENOUS	RLD	2020-11-05	`782e0a99824c…`

Observed Orange Book patent history#

Patent history page 1 of 10 · 370 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210864-001	7635773	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-001	8410077	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-001	9200088	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-001	9750822	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-001	9493582	2033-02-27	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-002	7635773	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-002	8410077	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-002	9200088	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-002	9750822	2029-03-13	Drug product	2020-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210864-002	9493582	2033-02-27	Drug product	2020-12-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210864-001	7635773	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-001	8410077	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-001	9200088	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-001	9750822	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-001	9493582	2033-02-27	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-002	7635773	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-002	8410077	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-002	9200088	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-002	9750822	2029-03-13	Drug product	2020-12-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210864-002	9493582	2033-02-27	Drug product	2020-12-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-001	7635773	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-001	8410077	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-001	9200088	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-001	9750822	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-001	9493582	2033-02-27	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-002	7635773	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-002	8410077	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-002	9200088	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-002	9750822	2029-03-13	Drug product	2020-12-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210864-002	9493582	2033-02-27	Drug product	2020-12-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210864-001	7635773	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-001	8410077	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-001	9200088	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-001	9750822	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-001	9493582	2033-02-27	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-002	7635773	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-002	8410077	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-002	9200088	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-002	9750822	2029-03-13	Drug product	2020-12-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210864-002	9493582	2033-02-27	Drug product	2020-12-01	`6a471c1ec25d…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fosphenytoin sodium	FOSPHENYTOIN SODIUM	GLENMARK PHARMACEUTICALS INC., USA	a0def32c-e693-43e5-9509-0cef9642441c	2026-02-18	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin sodium	FOSPHENYTOIN SODIUM	GLENMARK PHARMACEUTICALS INC., USA	bb38bc6a-99c7-4cda-b3f0-37f629d060cf	2026-02-18	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
CEREBYX	FOSPHENYTOIN SODIUM	Pfizer Laboratories Div Pfizer Inc	d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a	2025-08-28	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
CEREBYX	FOSPHENYTOIN SODIUM	Pfizer Laboratories Div Pfizer Inc	de5a6711-4abb-4c3d-a18b-266b094ace11	2025-05-18	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin Sodium	FOSPHENYTOIN SODIUM	Sagent Pharmaceuticals	e1dab8ad-cbf6-4273-92fa-02629de2abde	2024-12-18	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin Sodium	FOSPHENYTOIN SODIUM	Amneal Pharmaceuticals LLC	87ff8a91-5b37-401c-b75c-dc6efd348761	2024-10-25	Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin Sodium	FOSPHENYTOIN SODIUM	Hikma Pharmaceuticals USA Inc.	519a44e3-8a93-456c-b71c-894513810d45	2024-04-10	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin sodium	FOSPHENYTOIN SODIUM	Gland Pharma Limited	49b08648-6a83-42c7-ae7b-80c29f2534fc	2023-10-17	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin	FOSPHENYTOIN SODIUM	Fresenius Kabi USA, LLC	b60c9c82-e5c7-4e05-98c7-5bbba4af04b2	2023-03-31	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM
Fosphenytoin Sodium	FOSPHENYTOIN SODIUM	West-Ward Pharmaceuticals Corp	c92df63b-5140-4213-8d43-8327ff6230b7	2018-01-04	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: FOSPHENYTOIN SODIUM

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 2 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
80674-102	Sesquient	fosphenytoin sodium	Sedor Pharmaceuticals, LLC	NDA	Current
80674-210	Sesquient	fosphenytoin sodium	Sedor Pharmaceuticals, LLC	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
67160	ORIG	2021-04-23
65173	ORIG	2020-11-09
65166	ORIG	2020-11-09